Crossmark

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Crossref DOI link: https://doi.org/10.1007/s13760-017-0816-5

Published Online: 2017-07-27

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niemantsverdriet, Ellis

Valckx, Sara

Bjerke, Maria

Engelborghs, Sebastiaan http://orcid.org/0000-0003-0304-9785
Funding

Funding for this research was provided by:

EU/EFPIA Innovative Medicines Initiative Joint Undertaking (115372)
License Information

License valid from 2017-07-27